Identification of Missing Carbon Fixation Enzymes as Potential Drug Targets in Mycobacterium Tuberculosis
Metabolic adaptation to the host environment has been recognized as an essential
mechanism of pathogenicity and the growth of Mycobacterium tuberculosis (Mtb) in the …
mechanism of pathogenicity and the growth of Mycobacterium tuberculosis (Mtb) in the …
Metabolomics of Central Carbon Metabolism in Mycobacterium tuberculosis
AD Baughn, KY Rhee - Molecular Genetics of Mycobacteria, 2014 - Wiley Online Library
Central carbon metabolism (CCM)—defined as the enzymatic transformation of carbon
through glycolysis, the pentose phosphate pathway (PPP), the citric acid cycle, the …
through glycolysis, the pentose phosphate pathway (PPP), the citric acid cycle, the …
High quality genome-scale metabolic network reconstruction of mycobacterium tuberculosis and comparison with human metabolic network: application for drug …
S Kalapanulak - 2009 - era.ed.ac.uk
Mycobacterium tuberculosis (Mtb), a pathogenic bacterium, is the causative agent in the vast
majority of human tuberculosis (TB) cases. Nearly one-third of the world's population has …
majority of human tuberculosis (TB) cases. Nearly one-third of the world's population has …
Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ 661 and proposing alternative drug targets
N Jamshidi, BØ Palsson - BMC systems biology, 2007 - Springer
Background: Mycobacterium tuberculosis continues to be a major pathogen in the third
world, killing almost 2 million people a year by the most recent estimates. Even in …
world, killing almost 2 million people a year by the most recent estimates. Even in …
Systems level mapping of metabolic complexity in Mycobacterium tuberculosis to identify high-value drug targets
R Vashisht, AG Bhat, S Kushwaha, A Bhardwaj… - Journal of Translational …, 2014 - Springer
Background The effectiveness of current therapeutic regimens for Mycobacterium
tuberculosis (Mtb) is diminished by the need for prolonged therapy and the rise of drug …
tuberculosis (Mtb) is diminished by the need for prolonged therapy and the rise of drug …
Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis
S Anishetty, M Pulimi, G Pennathur - Computational biology and chemistry, 2005 - Elsevier
The emergence of multidrug resistant varieties of Mycobacterium tuberculosis has led to a
search for novel drug targets. We have performed an insilico comparative analysis of …
search for novel drug targets. We have performed an insilico comparative analysis of …
Bioinformatics Analysis to Uncover the Potential Drug Targets Responsible for Mycobacterium tuberculosis Peptidoglycan and Lysine Biosynthesis
D Ayu Eka Pitaloka, A Izzati… - … and Biology Insights, 2023 - journals.sagepub.com
Drug-resistant tuberculosis (TB), which results mainly from the selection of naturally resistant
strains of Mycobacterium tuberculosis (MTB) due to mismanaged treatment, poses a severe …
strains of Mycobacterium tuberculosis (MTB) due to mismanaged treatment, poses a severe …
Integrated gene co-expression network analysis in the growth phase of Mycobacterium tuberculosis reveals new potential drug targets
We have carried out weighted gene co-expression network analysis of Mycobacterium
tuberculosis to gain insights into gene expression architecture during log phase growth. The …
tuberculosis to gain insights into gene expression architecture during log phase growth. The …
[HTML][HTML] High-Throughput Screen for Cell Wall Synthesis Network Module in Mycobacterium tuberculosis Based on Integrated Bioinformatics Strategy
X Luo, J Pan, Q Meng, J Huang, W Wang… - … in Bioengineering and …, 2020 - frontiersin.org
Background Mycobacterium tuberculosis is one of the deadliest pathogens in humans. Co-
infection of M. tuberculosis with HIV and the emergence of multi-drug-resistant tuberculosis …
infection of M. tuberculosis with HIV and the emergence of multi-drug-resistant tuberculosis …
Metabolic adaptation of two in silico mutants of Mycobacterium tuberculosis during infection
VA López-Agudelo, A Baena, H Ramirez-Malule… - BMC Systems …, 2017 - Springer
Abstract Background Up to date, Mycobacterium tuberculosis (Mtb) remains as the worst
intracellular killer pathogen. To establish infection, inside the granuloma, Mtb reprograms its …
intracellular killer pathogen. To establish infection, inside the granuloma, Mtb reprograms its …
相关搜索
- mycobacterium tuberculosis drug targets
- mycobacterium tuberculosis carbon substrates
- mycobacterium tuberculosis metabolic network
- metabolic complexity drug targets
- pathway analysis drug targets
- growth phase drug targets
- mycobacterium tuberculosis growth phase
- lysine biosynthesis drug targets
- mycobacterium tuberculosis pathway analysis
- mycobacterium tuberculosis silico mutants
- mycobacterium tuberculosis genome scale
- mycobacterium tuberculosis high quality
- mycobacterium tuberculosis carbon metabolism
- mycobacterium tuberculosis metabolic adaptation
- metabolic capabilities drug targets
- mycobacterium tuberculosis metabolic complexity